Comparison of the Generic and Original Formulation of Clopidogrel Regarding the Potency of Platelet Inhibition in Patients After PCI.

Trial Profile

Comparison of the Generic and Original Formulation of Clopidogrel Regarding the Potency of Platelet Inhibition in Patients After PCI.

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Dec 2011

At a glance

  • Drugs Clopidogrel (Primary)
  • Indications Thrombosis
  • Focus Pharmacodynamics
  • Acronyms DOSER-GENERIC
  • Most Recent Events

    • 24 Dec 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top